Investor profile
Frazier Healthcare Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Frazier Healthcare Partners is a dedicated healthcare private equity firm founded in 1991, with over $11 billion in institutional capital raised across more than 200 investments. The firm's Growth Buyout strategy focuses on acquiring controlling interests in profitable, lower-middle-market healthcare companies — spanning healthcare services, pharmaceutical services, medical products, and healthcare IT — with target EBITDA of $5M–$50M. Frazier pairs high-conviction, thesis-driven investment themes with proven operating executives sourced through its Executive in Residence (EIR) program, and deploys an in-house Center of Excellence providing functional support across M&A, commercial strategy, human capital, data & AI, technology, and finance/operations to drive scale and long-term value. The firm also maintains a Life Sciences strategy investing in private and publicly traded biopharmaceutical companies addressing unmet medical needs through innovation.
Notable quotes
“Frazier's ability to identify emerging industry trends in advance of the broader market, and our thesis-driven Executive in Residence (EIR)-centric model, provide us with a distinct advantage. Our sustained access to proven executive talent is paired with these investment theses to build sustainable healthcare companies that play into these themes.”
“Our thesis-driven, executive in residence-centered strategy has enabled the Frazier franchise to become a preferred partner to both serially successful executives and sellers of companies in targeted sectors of interest.”
“We're not looking for development stage companies with this fund. Of course, the companies we're interested in are relatively small in the grand scheme of things – but they're not R&D, which are losing money.”
Team
Ben Magnano
Managing Partner
Brian Morfitt
General Partner
Nader Naini
Managing Partner
Nathan Every, MD
General Partner
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Altruix | Buyout | — | 2026-05-28 |
| Knipper Health | Buyout | — | 2025-02-01 |
| Tri-Imaging Solutions | Buyout | — | 2024-01-01 |
| RevSpring | Buyout | — | 2024-03-12 |
| BioMatrix Holdings | Buyout | — | 2024-06-25 |
| AirLife | Buyout | — | 2021-01-01 |
| Adare Pharma Solutions | Buyout | — | 2020-01-01 |
| Accuity Delivery Systems | Buyout | — | 2020-01-01 |
| CHG Healthcare Services | Buyout | — | 2005-01-01 |
| Bravo Health | Buyout | — | 2004-01-01 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| New Enterprise Associates (NEA) | 20 |
| OrbiMed | 19 |
| MPM Capital | 17 |
| Versant Ventures | 16 |
| Canaan Partners | 14 |
| InterWest Partners | 13 |
Fit check
Is Frazier Healthcare Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit